26/120
1.1 / 5 stars
All 120 Win/Lose results shown below
CLOV Roast Me summary
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV). Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
- 2026-Q2: Total return Win; Revenue growth Win; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2025-Q3: Total return Win; Revenue growth Win; EPS growth Lose.
Trailing 1 year (4 quarters): 6 wins, 6 lossesLast fetched: 25 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q22/3 |
WinCLOV / S&P 197.73% / 15.20% |
WinCLOV / S&P 54.03% / 15.00% |
LoseCLOV / S&P CLOV unavailable / 50.40% |
| 2026-Q11/3 |
LoseCLOV / S&P -25.11% / -4.33% |
WinCLOV / S&P 48.75% / 11.30% |
LoseCLOV / S&P CLOV unavailable / 27.70% |
| 2025-Q41/3 |
LoseCLOV / S&P -23.20% / 2.65% |
WinCLOV / S&P 40.34% / 9.00% |
LoseCLOV / S&P CLOV unavailable / 13.40% |
| 2025-Q32/3 |
WinCLOV / S&P 9.68% / 8.12% |
WinCLOV / S&P 31.71% / 4.61% |
LoseCLOV / S&P CLOV unavailable / 13.45% |
| 2025-Q21/3 |
LoseCLOV / S&P -22.28% / 10.94% |
WinCLOV / S&P 21.66% / 4.83% |
LoseCLOV / S&P CLOV unavailable / 10.63% |
| 2025-Q12/3 |
WinCLOV / S&P 13.97% / -4.27% |
WinCLOV / S&P 15.64% / 4.98% |
LoseCLOV / S&P CLOV unavailable / 10.57% |
| 2024-Q42/3 |
WinCLOV / S&P 11.70% / 2.41% |
WinCLOV / S&P 8.77% / 5.25% |
LoseCLOV / S&P CLOV unavailable / 6.15% |
| 2024-Q31/3 |
WinCLOV / S&P 129.27% / 5.89% |
LoseCLOV / S&P CLOV unavailable / 5.89% |
LoseCLOV / S&P CLOV unavailable / 6.11% |
| 2024-Q22/3 |
WinCLOV / S&P 54.91% / 4.28% |
WinCLOV / S&P 7407.78% / 5.38% |
LoseCLOV / S&P CLOV unavailable / 5.12% |
| 2024-Q11/3 |
LoseCLOV / S&P -16.60% / 10.56% |
WinCLOV / S&P 136.23% / 5.71% |
LoseCLOV / S&P CLOV unavailable / 5.59% |
| 2023-Q41/3 |
LoseCLOV / S&P -11.85% / 11.69% |
WinCLOV / S&P 14.96% / 6.81% |
LoseCLOV / S&P CLOV unavailable / 7.78% |
| 2023-Q31/3 |
WinCLOV / S&P 20.40% / -3.27% |
LoseCLOV / S&P -117.71% / 7.52% |
LoseCLOV / S&P CLOV unavailable / -5.03% |
| 2023-Q20/3 |
LoseCLOV / S&P 6.15% / 8.74% |
LoseCLOV / S&P -99.32% / 9.50% |
LoseCLOV / S&P CLOV unavailable / -8.57% |
| 2023-Q10/3 |
LoseCLOV / S&P -9.14% / 7.50% |
LoseCLOV / S&P -74.64% / 10.77% |
LoseCLOV / S&P CLOV unavailable / -15.69% |
| 2022-Q40/3 |
LoseCLOV / S&P -45.29% / 7.56% |
LoseCLOV / S&P -25.51% / 11.88% |
LoseCLOV / S&P CLOV unavailable / -17.99% |
| 2022-Q31/3 |
LoseCLOV / S&P -20.56% / -4.88% |
WinCLOV / S&P 149.54% / 13.47% |
LoseCLOV / S&P CLOV unavailable / -1.41% |
| 2022-Q21/3 |
LoseCLOV / S&P -39.72% / -16.10% |
WinCLOV / S&P 172.15% / 13.71% |
LoseCLOV / S&P CLOV unavailable / 11.04% |
| 2022-Q12/3 |
WinCLOV / S&P -4.57% / -4.60% |
WinCLOV / S&P 203.24% / 15.97% |
LoseCLOV / S&P CLOV unavailable / 42.23% |
| 2021-Q41/3 |
LoseCLOV / S&P -49.66% / 11.03% |
WinCLOV / S&P 118.76% / 15.00% |
LoseCLOV / S&P CLOV unavailable / 96.40% |
| 2021-Q30/3 |
LoseCLOV / S&P -44.52% / 0.58% |
LoseCLOV / S&P CLOV unavailable / 10.77% |
LoseCLOV / S&P CLOV unavailable / 69.42% |
| 2021-Q21/3 |
WinCLOV / S&P 76.19% / 8.55% |
LoseCLOV / S&P CLOV unavailable / 6.58% |
LoseCLOV / S&P CLOV unavailable / 51.81% |
| 2021-Q10/3 |
LoseCLOV / S&P -54.92% / 6.17% |
LoseCLOV / S&P CLOV unavailable / -1.06% |
LoseCLOV / S&P CLOV unavailable / 7.39% |
| 2020-Q42/3 |
WinCLOV / S&P 34.59% / 12.15% |
WinCLOV / S&P 45.56% / -3.72% |
LoseCLOV / S&P CLOV unavailable / -33.42% |
| 2020-Q31/3 |
WinCLOV / S&P 11.45% / 8.93% |
LoseCLOV / S&P CLOV unavailable / -2.04% |
LoseCLOV / S&P CLOV unavailable / -27.10% |
| 2020-Q20/3 |
LoseCLOV / S&P CLOV unavailable / 20.54% |
LoseCLOV / S&P CLOV unavailable / -0.46% |
LoseCLOV / S&P CLOV unavailable / -27.11% |
| 2020-Q10/3 |
LoseCLOV / S&P CLOV unavailable / -19.60% |
LoseCLOV / S&P CLOV unavailable / 3.47% |
LoseCLOV / S&P CLOV unavailable / -14.75% |
| 2019-Q40/3 |
LoseCLOV / S&P CLOV unavailable / 9.07% |
LoseCLOV / S&P CLOV unavailable / 5.36% |
LoseCLOV / S&P CLOV unavailable / 2.99% |
| 2019-Q30/3 |
LoseCLOV / S&P CLOV unavailable / 1.70% |
LoseCLOV / S&P CLOV unavailable / 5.02% |
LoseCLOV / S&P CLOV unavailable / 0.21% |
| 2019-Q20/3 |
LoseCLOV / S&P CLOV unavailable / 4.30% |
LoseCLOV / S&P CLOV unavailable / 6.64% |
LoseCLOV / S&P CLOV unavailable / 8.65% |
| 2019-Q10/3 |
LoseCLOV / S&P CLOV unavailable / 13.65% |
LoseCLOV / S&P CLOV unavailable / 8.12% |
LoseCLOV / S&P CLOV unavailable / 14.29% |
| 2018-Q40/3 |
LoseCLOV / S&P CLOV unavailable / -13.52% |
LoseCLOV / S&P CLOV unavailable / 9.05% |
LoseCLOV / S&P CLOV unavailable / 18.23% |
| 2018-Q30/3 |
LoseCLOV / S&P CLOV unavailable / 7.71% |
LoseCLOV / S&P CLOV unavailable / 10.21% |
LoseCLOV / S&P CLOV unavailable / 19.06% |
| 2018-Q20/3 |
LoseCLOV / S&P CLOV unavailable / 3.43% |
LoseCLOV / S&P CLOV unavailable / 9.03% |
LoseCLOV / S&P CLOV unavailable / 14.46% |
| 2018-Q10/3 |
LoseCLOV / S&P CLOV unavailable / -0.76% |
LoseCLOV / S&P CLOV unavailable / 7.68% |
LoseCLOV / S&P CLOV unavailable / 12.46% |
| 2017-Q40/3 |
LoseCLOV / S&P CLOV unavailable / 6.64% |
LoseCLOV / S&P CLOV unavailable / 7.03% |
LoseCLOV / S&P CLOV unavailable / 13.82% |
| 2017-Q30/3 |
LoseCLOV / S&P CLOV unavailable / 4.48% |
LoseCLOV / S&P CLOV unavailable / 5.68% |
LoseCLOV / S&P CLOV unavailable / 17.57% |
| 2017-Q20/3 |
LoseCLOV / S&P CLOV unavailable / 3.09% |
LoseCLOV / S&P CLOV unavailable / 4.83% |
LoseCLOV / S&P CLOV unavailable / 17.74% |
| 2017-Q10/3 |
LoseCLOV / S&P CLOV unavailable / 6.07% |
LoseCLOV / S&P CLOV unavailable / 3.67% |
LoseCLOV / S&P CLOV unavailable / 13.32% |
| 2016-Q40/3 |
LoseCLOV / S&P CLOV unavailable / 3.82% |
LoseCLOV / S&P CLOV unavailable / 2.09% |
LoseCLOV / S&P CLOV unavailable / 7.05% |
| 2016-Q30/3 |
LoseCLOV / S&P CLOV unavailable / 3.85% |
LoseCLOV / S&P CLOV unavailable / 0.20% |
LoseCLOV / S&P CLOV unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-28
| Metric | CLOV total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 61.07% | 20.78% |
| Annualized return | 61.07% | 20.78% |
5Y · 2021-09-01 to 2026-08-28
| Metric | CLOV total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -50.18% | 83.14% |
| Annualized return | -13.01% | 12.86% |
10Y · 2020-06-12 to 2026-08-28
| Metric | CLOV total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -58.63% | 319.30% |
| Annualized return | -8.45% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-25.